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Rheumatoid Arthritis (RA) and chronic and aggressive periodontitis are chronic inﬂammatory disorders
characterized by deregulation of the host inﬂammatory response. Increased secretion of pro-inﬂam-
matory mediators results in soft and hard tissue destruction of the synovium and periodontium
respectively. Both diseases share risk factors and have pathological pathways in common, resulting in
loss of function and disability as a ﬁnal clinical outcome. This article discusses possible interactions,
particularly related to the periodontal pathogen Porphyromonas gingivalis, which could explain the
observed association between these two prevalent diseases.
 2011 Elsevier Ltd. All rights reserved.1. Periodontal disease
Supragingival plaque accumulation results in an inﬂammatory
response of the gums and is called gingivitis. This infection can be
eliminated by reduction of the total bacterial load through simple
oral hygiene measures. When the infection proceeds, destructive
periodontal disease or periodontitis can develop in susceptible
individuals. Periodontitis is an infective process with destruction
of the supporting soft and hard tissue of the teeth (the perio-
dontium) as a consequence. It can be can be characterized as
chronic (slowly progressive) or aggressive (highly destructive)
forms of periodontitis. Further classiﬁcation can be made on the
extent (localized/generalized) and severity (mild/moderate/
severe) of the disease [1]. Clinical signs of the disease are bleeding
gums, deepened periodontal pockets, suppuration and in an
advanced stage, mobility of the teeth with tooth loss as the ﬁnal
disease outcome due to extensive loss of alveolar bone. Perio-
dontitis is a multifactorial, bacterial driven, chronic inﬂammatory
disorder that occurs in 10e15% of an adult population, indepen-
dent of ethnicity and geographic location [2]. It is the major factor
for tooth loss over the age of 35 years. Bacteria play a major role in
etiology; it is thought that the bioﬁlm in the subgingival area
causes a chronic inﬂammatory response that is responsible forSmit).
All rights reserved.destruction of the alveolar bone and soft tissue surrounding the
teeth (the periodontium). The subgingival bioﬁlm in periodontal
lesions consists of hundreds of bacterial species, most of which are
strict anaerobic and of which a signiﬁcant part is non-cultivable.
Cultivable microbial indicators for periodontitis are, among
others, Aggregatibacter actinomycetemcomitans, Porphyromonas
gingivalis, Prevotella intermedia, Parvimonas micra, Treponema
species and Tannerella forsythia [3].
Although bacteria are essential for periodontal disease to
occur, a susceptible host is also required. It is thought that
susceptibility is determined by genetic traits and lifestyle factors
such as smoking and stress. Identiﬁed risk factors for the initia-
tion of periodontitis are subgingival calculus and subgingival
detection of A. actinomycetemcomitans [4]. Risk indicators for
progression of the disease include smoking [5], age, stress and
psychological factors [6] and existing attachment loss [7]. Other
putative risk factors involve gender, education, socio-economic
status [8], nutritional factors [9] and body mass index [6,10].
2. Periodontitis is not a local phenomenon
In generalized severe chronic and aggressive periodontitis the
infected and necrotic epithelium surface area amounts up to
20 cm2. Periodontal lesions may lead to bacteremia that can be the
cause of focal infection of dental origin [11e13]. Severe perio-
dontitis also results in a continuous systemic inﬂammatory
response [14e16]. Periodontitis has been associated with a number
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litus [17], atherosclerosis, cardiovascular disease and stroke [18],
rheumatoid arthritis [19,20], Crohn’s disease and ulcerative colitis
[21] and preterm birth and low birth weight [22]. In this paper
we review current knowledge on the association of periodontitis
and rheumatoid arthritis and discuss possible mechanisms of
interactions between the two disorders.
3. Rheumatoid arthritis and anti-citrullinated protein
antibodies
Rheumatoid arthritis (RA) is a chronic inﬂammatory poly-
arthritis with a prevalence of 0.5%e1.0% of adults in industrialized
countries. The disease is far more common among women than
men (3:1) and prevalence rises with age, with a peak in the ﬁfth
decade [23]. The etiology is multifactorial and the pathogenesis is
poorly understood. Autoimmunity to citrullinated proteins is highly
speciﬁc for RA and may be of pathogenic signiﬁcance [24]. Risk of
developing RA is of 50% attributable to genetic factors [25].
Smoking is the major known environmental risk factor for RA.
Smoking and genetic risk factors interact in providing an increased
risk of RA [26]. Immune responses with several inﬂammatory
cascades lead toward a ﬁnal common pathway with persistent
synovial inﬂammation and associated damage to articular cartilage
and underlying bone as a consequence. There is evidence of
a preclinical or asymptomatic phase of the disease, in which auto-
antibodies can be already be present [27]. The auto-antibodiesmost
frequently found in patients with RA are antibodies which bind to
the constant domain of IgGmolecules (IgM rheumatoid factor, IgM-
RF) and antibodies against citrullinated proteins (anti-citrullinated
protein antibodies, ACPA). The majority of individuals with RA
(50e80%) have serum positive titers for IgM-RF and/or ACPA. ACPA
have a higher speciﬁcity (98%) and sensitivity (up to 80%) for
diagnosis of RA than IgM-RF [28]. ACPA seem to be better predictors
of poor prognosis of RA; ACPA-positive RA is associated with
increased joint damage and low remission rates [29]. ACPA exist in
around 2% of normal populations and are rare in other inﬂamma-
tory conditions [30]. ACPA were originally measured as antibodies
against keratin (the anti-perinuclear factor) [31], and more recently
as anti-cyclic citrullinated peptides (anti-CCP) [32]. These auto-
antibodies recognize epitopes containing citrulline. Citrulline is
a nonstandard amino acid, and is therefore not incorporated in
proteins during translation. However, it can be generated by post-
translational modiﬁcation (citrullination) of protein-bound
arginine by peptidylarginine deiminase (PAD) enzymes. This post-
translational modiﬁcation may have a big impact on the structure
and function of the target protein, partly due to a change of charge.
Citrullination is an inﬂammation-associated phenomenon, occur-
ring in a wide range of tissues. It is predominantly observed in
proteins of the cytoskeleton. It seems to represent a general regu-
latory mechanism, particularly occurring during apoptosis. So far,
ﬁve isotypes of PAD have been described in humans. All these
enzymes rely strongly on the presence of calcium for activity and
are unable to convert free L-arginine into L-citrulline, which can be
done by nitric oxide synthase in eukaryotes or by arginine deimi-
nase in bacteria. Because of their calcium dependency, PAD
enzymes are more likely to be active in the extracellular compart-
ment. PAD2 and PAD4 are found in synovial ﬂuid and in synovial
tissue of RA patients and are therefore the most likely candidate
PAD isotypes for the citrullination of synovial proteins in RA [33].
Smoking enhances PAD2 expression in human lungs with conse-
quent generation of citrullinated proteins in the bronchoalveolar
compartment [34]. Recently, PAD2 expression and citrullinated
proteins have also been detected in the periodontium [35].
Whereas citrullination is associated with inﬂammation in general,the development of antibodies against them (ACPA) is speciﬁc to
RA. The high speciﬁcity of ACPA is thereforemost likely the result of
an abnormal humoral response to these proteins. ACPA are
produced locally in the inﬂamed synovium [36], suggesting that the
resulting immune complexes are directly involved in the disease
pathogenesis of the chronic inﬂammation in the rheumatoid joint.
If there is local ACPA production in the periodontium or in the
bronchoalveolar compartment remains to be established, albeit
higher ACPA reactivity in serum samples of aggressive periodontitis
patients has been reported [37].
3.1. Similarities between RA and periodontitis
There are remarkable similarities between RA and chronic and/
or aggressive periodontitis. Both diseases are chronic destructive
inﬂammatory disorders characterized by deregulation of the host
inﬂammatory response. The etiology of both diseases is multifac-
torial and susceptibility to the diseases is inﬂuenced by shared
genetic and lifestyle factors. Both diseases are cumulative, i.e.
severity, loss of function and quality of life decrease with longer
disease duration. There are common pathological mechanisms;
both conditions are potentiated by an exaggerated inﬂammatory
response featuring an increase in localized and perhaps circulating
pro-inﬂammatory mediators, resulting in soft and hard tissue
destruction of the periodontium and synovium respectively.
A number of clinical studies point toward an association
between periodontal disease and RA [38], despite the fact that
patients suffering from RA are often treated with immune
suppressant corticosteroids, thereby possibly reducing clinical
evidence of periodontal disease. An important observation is that
treatment of periodontal disease has a positive effect on disease
activity of RA [39], although this observation needs further conﬁr-
mation. Surprisingly, none of the studies on RA and periodontal
disease considered microbiology, although bacteria play a primary
role in the etiology of periodontal disease. Similarities in risk
factors, common pathological pathways, association in prevalence
and the effect of periodontal treatment on RA make us look further
to explore the relation between periodontitis and RA, with a special
focus on microbiology.
4. The Bradford Hill approach
To describe the strength and nature of an association between
two disorders, the widely used Bradford Hill criteria to determine
a causal association are applied [40]. These involve strength,
consistency, speciﬁcity, temporality, biological gradient, plausi-
bility, coherence, experimental evidence and analogy of the asso-
ciation. Starting from epidemiologic evidence, four issues need to
be addressed: strength, consistency, temporal relation, and
analogy. The third National Health and Nutrition Examination
Survey (NHANES III) is a nationally representative cross-sectional
survey of non-institutionalized US population. Using this data, de
Pablo et al. [41] included participants aged 60 years who had
undergone both musculoskeletal and dental examinations
(n ¼ 4461). They found that subjects classiﬁed with RA, according
to the American College of Rheumatology (ACR) criteria of 1987
(n ¼ 103), were more likely to suffer from periodontitis, after
adjusting for age, sex, ethnicity and smoking. Considering three out
of six ACR criteria, they found an odds ratio (OR) of 1.8, considering
four out of six ACR criteria an OR of 4.1. Participants with RA had
signiﬁcant more missing teeth than participants without RA.
Comparing periodontal status in 65 RA patients (according to the
ACR criteria 1987) with an age- and gender-matched control group
(age range 20e70 years) without RA, Mercado et al. [42] found that
individuals with RA are more likely to experience more periodontal
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the RA group showed signiﬁcant more missing teeth compared to
the non-RA group, an observation that conﬁrms previous ﬁndings
[43,44]. Indicators of disease activity for RA most positively corre-
latedwith periodontal bone loss were the number of swollen joints,
health assessment questionnaire scores, levels of C-reactive protein
and erythrocyte sedimentation rates. The other way around, in
1412 individuals attending the University of Queensland’s School of
Dentistry, Mercado et al. [45] found that self-reported RA was
signiﬁcantly higher in patients referred for periodontal treatment
(n ¼ 809) compared to patients not referred for periodontal treat-
ment (3.95% vs. 0.66%). Nesse et al. [20] found in a cross-sectional
study an increased prevalence of RA in patients with perio-
dontitis, which could not be explained by the confounding factors
sex, age and smoking. Coherence of the association is inﬂuenced by
variation in design, setting, methods, selection bias and the fact
that the majority of the studies on this association are low-
prevalence case-control studies with no consistent criteria to
deﬁne periodontitis. With respect to temporal relation, speciﬁc
auto-antibodies (IgM-RF and ACPA) precede the symptoms of RA
[27]. Half of patients with RA have speciﬁc serologic abnormalities
several years (median 4.5 years) before the development of clinical
symptoms. Besides the analogy of the characteristics of the pop-
ulation to which the diseases are exposed, the two diseases have
pathological mechanisms in common and they share environ-
mental and genetic risk factors. If there is a doseeresponse relation
between the two diseases is currently unknown. The available
studies on association of periodontitis and RA did not quantify the
extent of periodontal disease, but is now possible with the Peri-
odontal Inﬂamed Surface Area (PISA) index for inﬂammatory
burden [46]. Nevertheless, antibody titers to the periodontal
pathogen P. gingivalis are increased in patients with RA and there
are signiﬁcant positive correlations between P. gingivalis antibody
titers, CRP concentrations and antibody titers to citrullinated
proteins, i.e. to disease speciﬁc immunity [47]. Biological plausi-
bility is partly explained by this association, and the fact that
periodontitis causes an inﬂammatory burden by eliciting a systemic
inﬂammatory response. Antibody response to P. gingivalis and DNA
of P. gingivalis self have been found in synovial ﬂuid of RA patients
[48e50]. Experimental evidence is drawn from two controlled
studies that have been conducted on the effect of periodontal
treatment on RA [39,51]. Both studies showed that periodontal
therapy had a beneﬁcial effect on laboratory RA parameters and
clinical symptoms of RA. Because these studies had a small sample
size and did not consider microbiology, there is a crying need for
better designed experimental studies on the effect of periodontal
treatment on RA disease activity.
5. Genetic factors in RA and periodontal disease
In both diseases, candidate gene approach revealed mainly
genetic variations in genes encoding for elements of the innate
immune system as a risk indicator. More than 30 genetic regions
are associated with RA. Genetic variations in the major histocom-
patibility complex, class II, DR beta 1 (HLA-DRB1) and protein
tyrosine phosphatase (PTPN22) genes are the major genetic risk
indicators that have been reproducibly identiﬁed so far. The asso-
ciation of a number of speciﬁc HLA-DRB1 alleles is seen exclusively
for the ACPA-positive subset of RA [52]. These HLA alleles share
a commonpeptide-bindingmotif known as the shared epitope (SE).
Antigen modiﬁcation by protein citrullination is thought to allow
antigens to ﬁt in the HLA alleles that hold this SE. The result is
breaking of tolerance and antibody formation against these anti-
gens [53]. The PTPN22 gene codes for a tyrosine phosphatase, with
a potential function in the regulation of T-cell and B-cell activation.The best-studied environmental factor in RA is smoking and this
seems to be a risk factor for ACPA-positive disease, especially in the
context of positivity for HLA-DRB1 SE alleles [54]. Studies have also
shown an additive interaction between PTPN22 and smoking. No
geneegene interaction was observed between PTPN22 and HLA-
DRB1 SE [55].
Genetic and lifestyle factors (smoking) have become the leading
susceptibility factors in periodontal disease. The family background
and the familial aggregation of early onset aggressive periodontitis
have long been recognized. This supports the connection between
certain genes’ mutation and periodontal diseasemanifestation. Like
RA, among candidate genes possibly associated with increased host
immune susceptibility to periodontitis are HLA-DR polymorphisms.
A signiﬁcant association was found between HLA-DRB1 SE and
severe periodontitis (chronic/aggressive), stratiﬁed according to
ethnogeographic origin [56]. Several single nucleotide poly-
morphisms, notably in the IL1, IL6, IL10, vitamin D receptor, and
CD14 genes have been linked to severity and presence of destruc-
tive periodontal disease [57]. Genes that encode for IL-1 production
have received attention as potential predictors of periodontal
disease progression, because of its involvement in the regulation of
the host’s inﬂammatory response and bone resorption. IL-1 is not
only involved in signaling processes resulting in autoimmune
induced bone destruction but also in several hereditary auto-
inﬂammatory syndromes. Meta-analysis of four common promoter
SNPs in the IL1 region in British Caucasian patients revealed an
association with increased susceptibility to RA [58]. Irrespective of
smoking and presence of P. gingivalis and A. actinomycetemcomitans,
patients with severe periodontitis (chronic and/or aggressive)
showed a signiﬁcantly higher frequency of the positive IL1 genotype
than periodontally healthy individuals (42% vs. 11%, all Caucasian
subjects) [59]. In a study of 42 patients (1044 teeth) in maintenance
care for 14 years, the combined effect of a positive IL1 genotype and
smoking did increase the risk of tooth loss by 7.7 times, compared to
2.7 and 2.9 times for positive IL1 genotype and smoking separately
[60]. Also, gene polymorphisms in pro-inﬂammatory cytokines IL6
and the IL1 cluster are associated with systemic inﬂammation in
patients with severe periodontitis (chronic and/or aggressive, 65%
European Caucasians) [15].5.1. A link via citrullination
Given the fact that antibody formation against citrullinated
proteins plays a major role in autoimmunity in RA, and given the
fact that citrullination seems to be a unique feature for the peri-
odontal pathogen P. gingivalis, we hypothesize that the onset and
progression of RA is inﬂuenced by the presence of periodontal
infection with P. gingivalis.
The bacteria involved in periodontitis accumulate in a sub-
gingival bioﬁlm that comprises predominantly Gram negative strict
anaerobic rods. The group of dark-pigmented anaerobic rods is
strongly associated with destructive periodontal disease and the
major pathogen in this group is P. gingivalis [61]. The prevalence of
P. gingivalis in severe periodontitis is 70% and it has been infre-
quently isolated from subjects without periodontitis [3], suggesting
that this bacterium is not a normal inhabitant of a healthy perio-
dontium [62]. To date, the single prokaryotic enzyme that can cit-
rullinate proteins, has been identiﬁed in P. gingivalis [63]. Based on
the biochemical characteristics and properties of this PAD enzyme,
it could be a virulence agent. P. gingivalis PAD deiminates the gua-
nidino group of carboxyl-terminal arginine residues on a variety of
peptides, to yield ammonia and a citrulline residue. In contrast to
human PAD, it can convert both peptidylarginine and free L-argi-
nine and is not dependent on calcium [64].
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logical markers for RA, include anti-citrullinated keratin (the
anti-perinuclear factor), anti-citrullinated vimentin (formerly
known as the Sa-antigen), anti-citrullinated ﬁlaggrin, anti-
citrullinated ﬁbrin(ogen) and anti-citrullinated a-enolase anti-
bodies. Alpha-enolase is a multifunctional protein, best known for
its role in glucose metabolism andmore recently as a plasminogen-
binding protein on the surface of various mammalian and
prokaryotic cells [65,66]. In RA, the immunodominant epitope of
human a-enolase is citrullinated-enolase-peptide-1 (CEP-1). This
epitope (amino acids 5e21) shows 82% sequence similarity with
CEP-1 of P. gingivalis. The amino acids 13e21 are 100% identical.
Antibodies puriﬁed for afﬁnity to human CEP-1 cross-reacted with
CEP-1 of P. gingivalis [67].
Recently, Wegner et al. [68] showed that PAD from P. gingivalis is
able to citrullinate its endogenous proteins and more strikingly,
also human ﬁbrinogen and human a-enolase. This seems to be
a unique characteristic of P. gingivalis [58]. Thus, the immune
system in patients with periodontal infection with P. gingivalis is
exposed to citrullinated antigens that might become systemic
immunogens; directly, or via molecular mimicry and cross-
reactivity. Peridontal infection with P. gingivalis could contribute
to the total antigenic load of citrullinated proteins, generated by
host PAD during the inﬂammatory response and by bacterial PAD
produced as a virulence factor of P. gingivalis. In a geneticFig. 1. Possible interactions of periodontal infection with P. gingivalis in etiology and
pathogenesis of ACPA-positive RA. RA and periodontal infection share genetic traits,
lifestyle risk factors as smoking and geneeenvironmental interactions (for details see
text). Infection with P. gingivalis can cause bacteremia and generates a systemic
inﬂammatory response, thereby contributing to the total inﬂammatory burden. In
addition, P. gingivalis is able to citrullinate proteins. Given the fact that citrullination is
an inﬂammation-associated process, P. gingivalis contributes in two ways to the total
antigenic load of citrullinated proteins. Smoking contributes to citrullination as well. A
susceptible host forms antibodies against the citrullinated proteins (ACPA), which are
highly speciﬁc for RA. Immune-complex formation sustains synovial inﬂammation,
representative for the laboratory parameters and clinical symptoms of RA.susceptible host, for example in context of HLA-DRB1 SE, this could
result in a pathologic immune response, with the formation of
ACPA and joint inﬂammation as a consequence. Our hypothesis is
that periodontitis and RA are related through common genetic and
lifestyle risk factors, inﬂammatory burden, and in particular in
presence of P. gingivalis (Fig. 1). To come back to the Bradford Hill
criteria, biological plausibility is partly explained by the fact that
periodontitis causes a systemic inﬂammatory response. The asso-
ciation of P. gingivaliswith the RA-related anti-citrullinated protein
antibody response could be a second explanation of this associa-
tion. Sequence similarity and cross-reactivity with immunodo-
minant epitopes of citrullinated proteins and their bacterial
variants may indicate a role for P. gingivalis in autoimmunity in
patients with RA. To fulﬁll the Bradford Hill criteria in detail, studies
linking periodontal disease and RA need further investigation. If
there is a distinct relation, treatment of periodontitis is thought to
be of inﬂuence on disease activity of RA. By studying (pre)clinical
and (micro)biological markers of both diseases, we intend to
further unravel the pathogenic relation between periodontitis and
RA. Recognition of the association between RA and periodontitis on
both a clinical and biologic level may result in new opportunities
for intervention that will modify the course of these prevalent
debilitating chronic inﬂammatory disorders.
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